Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1804210Generated: October 31, 2026

(R)-4-(4-methyl-2-oxooxazolidin-3-yl)benzoic acid → (R)-3-{4-[4-(3-cyclopropyl-5-trifluoromethylpyridin-2-yl)piperazine-1-carbonyl]phenyl}-4-methyloxazolidin-2-one hydrochloride

https://huagongshe.com/reaction/1804210

Reaction equation

Participants

RoleNameHCIDCharge
Reactant(R)-4-(4-methyl-2-oxooxazolidin-3-yl)benzoic acidHCID 58484719—
Reactant1-(3-Cyclopropyl-5-trifluoromethylpyridin-2-yl)piperazine hydrochlorideHCID 67380779—
Product(R)-3-{4-[4-(3-cyclopropyl-5-trifluoromethylpyridin-2-yl)piperazine-1-carbonyl]phenyl}-4-methyloxazolidin-2-one hydrochlorideHCID 67380940111.9%

Reaction Steps

By reaction and treatment in the same manner as in Example 87 and using (R)-4-(4-methyl-2-oxooxazolidin-3-yl)benzoic acid (221 mg) described in Preparation Example 37 and 1-(3-cyclopropyl-5-trifluoromethylpyridin-2-yl)piperazine hydrochloride (615 mg) described in Preparation Example 76, the title compound (571 mg) was obtained.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08354401B2
Source datasetuspto-grants-2013_01
ORD IDord-086d19a35caf4e8eb6b96d3be9a694d9
Source noteuspto-grants-2013_01